Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2012 22:21 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports Financial Results for the Third Quarter FY2012

MORRISVILLE, N.C., March 15, 2012 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT), a development stage biomedical company focused on developing oxygen-rich intravenous and topical...
March 01, 2012 16:44 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Plan to Regionalize Its Sales & Marketing Efforts for Its Dermacyte(R) Oxygenating Skin Care Product Line

MORRISVILLE, N.C., March 1, 2012 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the Company has modified its sales and marketing effort to focus on the regional...
February 01, 2012 07:30 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics and Aurum Biosciences Enter Joint Research Agreement to Develop an Oxycyte(R)-Based Diagnostic Tool and Therapeutic for Acute Ischemic Stroke

MORRISVILLE, N.C., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) and privately held Aurum Biosciences Ltd. of Glasgow, Scotland, today jointly announced they have signed...
January 09, 2012 08:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Begin Clinical Study to Determine Efficacy of Dermacyte(R) in Relieving Histamine Induced Pruritus

MORRISVILLE, N.C., Jan. 9, 2012 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) announced today that enrollment for the company's first dermatological study...
December 19, 2011 09:20 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Names Two New Board Members With Pharmaceutical Industry, Product and Business Development Emphasis

MORRISVILLE, N.C., Dec. 19, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has named Chris A. Rallis, Executive-in-Residence at...
December 16, 2011 13:33 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports Second Quarter FY2012 Financial Results

MORRISVILLE, N.C., Dec. 16, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT), a development stage biomedical company focused on developing oxygen-rich intravenous and...
December 09, 2011 08:35 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Registered Financing for up to $7.5 Million in Gross Proceeds

MORRISVILLE, N.C., Dec. 9, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that it has entered into definitive agreements with institutional investors...
November 22, 2011 11:20 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Present at 23rd Annual Piper Jaffray Healthcare Conference

MORRISVILLE, N.C., Nov. 22, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that Chief Financial Officer and Interim CEO Michael Jebsen will present at...
October 27, 2011 16:45 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Voluntarily Withdraw Secondary Listing From SIX Swiss Stock Exchange

MORRISVILLE, N.C., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that the SIX Swiss Stock Exchange has approved the application filed by the...
September 30, 2011 17:59 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Names Dr. Ronald Blanck Chairman of the Board

MORRISVILLE, N.C., Sept. 30, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that Ronald R. Blanck, DO, was appointed Chairman of the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right